Microreactor microfluidic systems with human microsomes and hepatocytes for use in metabolite studies
- PMID: 15940424
- DOI: 10.1007/s10544-005-1589-9
Microreactor microfluidic systems with human microsomes and hepatocytes for use in metabolite studies
Abstract
In the area of drug discovery, high-speed synthesis has increased the number of drug candidates produced. These potential drugs need to be evaluated for their adsorption, distribution, metabolism, elimination, and toxicology (ADMET) properties as early in the drug development stage as possible. Previously, a potential drug's ADMET properties have been found out by using monolayer cell cultures and live animals. These methods can be costly, time-intensive, and impractical for screening the large amount of potential drugs created by combinatorial chemistry. A quick, small, inexpensive, and highly parallel device would be desirable to determine a drug candidate's properties (i.e., metabolism of the drug). Here we fabricate a microfluidic device entrapping human microsomes within poly(ethylene) glycol hydrogels thereby generating an in situ microreactor to assess a drug candidate's metabolic properties that can be coupled to analysis equipment. We show that microsomes can be entrapped without the loss of enzymatic activity during photopolymerization. Additionally, a microreactor utilizing hepatocytes was also created for comparison with the microsome microreactor.
Similar articles
-
Microfluidic cell culture systems for drug research.Lab Chip. 2010 Apr 21;10(8):939-56. doi: 10.1039/b921695b. Epub 2010 Jan 21. Lab Chip. 2010. PMID: 20358102 Review.
-
Micro/Nanofluidic device for single-cell-based assay.Biomed Microdevices. 2005 Mar;7(1):35-40. doi: 10.1007/s10544-005-6169-5. Biomed Microdevices. 2005. PMID: 15834518
-
A microfluidic platform for 3-dimensional cell culture and cell-based assays.Biomed Microdevices. 2007 Feb;9(1):25-34. doi: 10.1007/s10544-006-9016-4. Biomed Microdevices. 2007. PMID: 17103048
-
Microscale culture of human liver cells for drug development.Nat Biotechnol. 2008 Jan;26(1):120-6. doi: 10.1038/nbt1361. Epub 2007 Nov 18. Nat Biotechnol. 2008. PMID: 18026090
-
Microscale bioprocess optimisation.Curr Opin Biotechnol. 2006 Dec;17(6):611-8. doi: 10.1016/j.copbio.2006.10.006. Epub 2006 Nov 3. Curr Opin Biotechnol. 2006. PMID: 17084609 Review.
Cited by
-
Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells.Tissue Eng Part C Methods. 2015 Apr;21(4):413-22. doi: 10.1089/ten.TEC.2014.0152. Epub 2014 Nov 6. Tissue Eng Part C Methods. 2015. PMID: 25233394 Free PMC article.
-
Application of microfluidic chips in anticancer drug screening.Bosn J Basic Med Sci. 2022 Jun 1;22(3):302-314. doi: 10.17305/bjbms.2021.6484. Bosn J Basic Med Sci. 2022. PMID: 34627135 Free PMC article. Review.
-
Analytical tools and approaches for metabolite identification in early drug discovery.Pharm Res. 2007 Feb;24(2):248-57. doi: 10.1007/s11095-006-9162-7. Epub 2006 Oct 18. Pharm Res. 2007. PMID: 17048114 Review.
-
Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.Technology (Singap World Sci). 2015 Mar;3(1):1-26. doi: 10.1142/S2339547815300012. Technology (Singap World Sci). 2015. PMID: 26167518 Free PMC article.
-
In vitro platforms for evaluating liver toxicity.Exp Biol Med (Maywood). 2014 Sep;239(9):1180-1191. doi: 10.1177/1535370214531872. Epub 2014 Apr 24. Exp Biol Med (Maywood). 2014. PMID: 24764241 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources